Antigen–antibody immunogenic complex: promising novel vaccines for microbial persistent infections

Bibliography

• Terres G, Wolins W. Enhanced immunological sensitization of mice by the simultaneous injection of antigen and specific antiserum. I. Effect of varying the amount of antigen used relative to the antiserum. J Immunol 1961;86:361-8
   PubMed Web of Science ®Google Scholar
• Randall RE, Young DF, Southern JA. Immunization with solid matrix-antibody–antigen complexes containing surface or internal virus structural proteins protect mice from infection with the paramyxovirus, simian virus 5. J Gen Virol 1988;69:2517-26
   PubMed Web of Science ®Google Scholar
• Randall RE, Young DF. Solid matrix-antibody–antigen complexes induce specific CD8+ cells that clear a persistent paramyxovirus infection. J Virol 1991;65:719-26
   PubMed Web of Science ®Google Scholar
• Berzofsky JA, Bensussan A, Cease KB, et al. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature 1988;334:706-8
   PubMed Web of Science ®Google Scholar
• Nydegger UE. Immune-complex pathophysiology. Ann NY Acad Sci 2007;1109:66-83
   PubMed Web of Science ®Google Scholar
• Devey ME, Bleasdale K, Stanley C, Steward MW. Failure of affinity maturation leads to increased susceptibility to immune complex glomeruolonephritis. Immunology 1984;52:377-83
   PubMed Web of Science ®Google Scholar
• Wang WK, Chen HL, Yang CF, et al. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006;43:1023-30
   PubMed Web of Science ®Google Scholar
• Celis E, Zurawski VR, Chang TW. Regulation of T cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies. Proc Natl Acad Sci USA 1984;81:6846-50
   PubMed Web of Science ®Google Scholar
• Xiong SD, Zhang W, Wen YM. Establishment and verification of an animal model of immunological tolerance against hepatitis B virus. Acta Academiae Medicinae Shanghai 1993;20:321-6
   Google Scholar
• Wen YM, Zhang W, Xu YY, et al. Elimination of immune tolerance to hepatitis B in an animal model. Chin Med J 2002;105:199-203
   Google Scholar
• Wen YM, Xiong SD, Zhang W. Solid matrix-antibody–antigen complex can clear viremia and antigenemia in persistent duck hepatitis B virus infection. J Gen Virol 1994;78:335-9
   Google Scholar
• Wen YM, Qu D, Zhou SH. Antigen–antibody complex as therapeutic vaccine for viral hepatitis B. Int Rev Immunol 1999;15:251-8
   Google Scholar
• Zhou SH, Qu D, Wen YM, et al. Studies on HBsAg–anti-HBs complex inducing humoral immune responses. Chin J Microbiol Immunol 1998;18:331-5
   Google Scholar
• Zheng BJ, Ng MH, He LF, et al. Therapeutic efficacy of hepatitis B surface antigen–antibodies–recombinant DNA composite in HBsAg transgenic mice. Vaccine 2001;19:4219-25
   PubMed Web of Science ®Google Scholar
• Zheng BJ, Zhou J, Qu D, et al. Selective functional deficit in dendritic cell–T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 2004;11:217-24
   PubMed Web of Science ®Google Scholar
• Sodomann CP, Schmidt R, Martini GA. Circulating immune complexes (CIC) in acute and chronic viral hepatitis and their sequelae. In: Szmuness W, Alter HJ, Maynard JE, ediors, Viral hepatitis. The Franklin Institute Press, 1982. p. 791-2
   Google Scholar
• Zhang JM, Xu Y, Wang XY, et al. Coexistence of hepatitis B surface antigen and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Inf Dis 2007;44:1161-9
   PubMed Web of Science ®Google Scholar
• Wen Y, He L, Qu D. Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method. US6221664; 2001
   Google Scholar
• European patent 913157
   Google Scholar
• Xu DZ, Huang KL, Zhao K, et al. Vaccination with recombinant HBsAg–HBIG complex in healthy adults. Vaccine 2005;23:2658-64
   PubMed Web of Science ®Google Scholar
• Yao X, Zheng BJ, Zhou J, et al. Therapeutic effect of hepatitis B surface antigen–antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients. Vaccine 2007;25:1771-9
   PubMed Web of Science ®Google Scholar
• Xu DZ, Zhao K, Guo LM, et al. A randomized controlled Phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients. Plos One 2008;3:e2565. Published online 2 July 2008, doi:10.1371/journal.pone.0002565
   PubMed Web of Science ®Google Scholar
• Ma ZM, Tian XC, Li XX, et al. Studies on hepatitis B S gene mutation in chronic hepatitis B patients treated with HBsAg–HBIG immunogenic complex therapeutic vaccine. J Microbes Infect (Chinese) 2007;2:68-72
   Google Scholar
• Schuurhuis DH, Van Montfoort N, Ioan-Facsinay A, et al. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol 2006;176:4573-80
   PubMed Web of Science ®Google Scholar
• Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B, et al. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol 2002;168:2240-6
   PubMed Web of Science ®Google Scholar
• Wen YM, Yuan ZH, Yao X. Experimental and clinical studies on hepatitis B surface antigen-antibody complex therapeutic vaccine. In: Denyer DV, editor, Progress in Hepatitis B Research. Nova Science Publishers, Inc., New York, 2007. p. 203-16
   Google Scholar
• Yuen MF, Hui CK, Wu CH, et al. Long term follow-up of interferon-α treatment in Chinese patients with chronic hepatitis B infection. The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 2001;34:139-45
   PubMed Web of Science ®Google Scholar
• Akbar SMF, Furukawa S, Onji M, et al. Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers. Hepatol Res 2004;29:136-41
   PubMed Web of Science ®Google Scholar
• Huang X, Liu L, Ren L, et al. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses. Vaccine 2007;52:874-84
   Google Scholar
• Nimmerjahn F, Rovetch J. Fcγ receptors as regulators of immune responses. Nature Reviews Immunology 2008;8:34-47
   PubMed Web of Science ®Google Scholar
• Barabas AZ, Cole CD, Barabas AD, Lafreniere R. A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease. Ann NY Acad Sci 2007;1110:619-29
   PubMed Web of Science ®Google Scholar